Scientific Opinion on the substantiation of health claims related to “wheat dextrin” and maintenance of normal blood pressure (ID 844, 1682), maintenance of normal (fasting) blood concentrations of triglycerides (ID 844, 1682), maintenance of normal blood cholesterol concentrations (ID 844, 1682), reduction of post-prandial glycaemic responses (ID 845, 3096), increase in magnesium and/or calcium retention (ID 846, 3097), short chain fatty acid (SCFA) production in the bowel (ID 1681), decreasing potentially pathogenic gastro-intestinal microorganisms (ID 843, 1681) and maintenance of normal bowel function (ID 843, 1680) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
Meta data
Keywords
Wheat dextrin, blood pressure, triglycerides, cholesterol, post-prandial glycaemic responses, calcium, magnesium, retention, short chain fatty acids, gastro-intestinal microorganisms, bowel function, health claims
On request from
European Commission
Question Number
EFSA-Q-2008-1630
EFSA-Q-2008-1631
EFSA-Q-2008-1632
EFSA-Q-2008-1633
EFSA-Q-2008-2416
EFSA-Q-2008-2417
EFSA-Q-2008-2418
EFSA-Q-2008-3828
EFSA-Q-2008-3829
Panel members at the time of adoption
Carlo Agostoni, Jean-Louis Bresson, Susan Fairweather-Tait, Albert Flynn, Ines Golly, Hannu Korhonen, Pagona Lagiou, Martinus Løvik, Rosangela Marchelli, Ambroise Martin, Bevan Moseley, Monika Neuhäuser-Berthold, Hildegard Przyrembel, Seppo Salminen, Yolanda Sanz, Sean (J.J.) Strain, Stephan Strobel, Inge Tetens, Daniel Tomé, Hendrik van Loveren and Hans Verhagen
Contact
Abstract
No abstract available
© European Food Safety Authority, 2010